Chiang Mai Ram Medical Business Vergangene Ertragsentwicklung
Vergangenheit Kriterienprüfungen 5/6
Chiang Mai Ram Medical Business has been growing earnings at an average annual rate of 9.8%, while the Healthcare industry saw earnings growing at 14% annually. Revenues have been growing at an average rate of 8.3% per year. Chiang Mai Ram Medical Business's return on equity is 6.8%, and it has net margins of 5.2%.
Wichtige Informationen
9.8%
Wachstumsrate der Gewinne
9.7%
EPS-Wachstumsrate
Healthcare Wachstum der Industrie | 23.6% |
Wachstumsrate der Einnahmen | 8.3% |
Eigenkapitalrendite | 6.8% |
Netto-Marge | 5.2% |
Letzte Ertragsaktualisierung | 30 Jun 2024 |
Jüngste Aktualisierungen vergangener Leistungen
Keine Aktualisierungen
Recent updates
Aufschlüsselung der Einnahmen und Ausgaben
Wie Chiang Mai Ram Medical Business Geld verdient und ausgibt. Basierend auf den neuesten gemeldeten Einnahmen der letzten zwölf Monate.
Gewinn- und Umsatzhistorie
Datum | Einnahmen | Umsatz | Allgemeine und Verwaltungskosten | F&E-Ausgaben |
---|---|---|---|---|
30 Jun 24 | 5,345 | 279 | 726 | 0 |
31 Mar 24 | 5,243 | 242 | 731 | 0 |
31 Dec 23 | 5,144 | 218 | 712 | 0 |
30 Sep 23 | 4,980 | 160 | 713 | 0 |
30 Jun 23 | 4,906 | 187 | 681 | 0 |
31 Mar 23 | 5,242 | 453 | 663 | 0 |
31 Dec 22 | 5,269 | 504 | 658 | 0 |
30 Sep 22 | 5,475 | 577 | 621 | 0 |
30 Jun 22 | 5,210 | 564 | 590 | 0 |
31 Mar 22 | 4,575 | 326 | 558 | 0 |
31 Dec 21 | 4,244 | 292 | 529 | 0 |
30 Sep 21 | 3,858 | 258 | 523 | 0 |
30 Jun 21 | 3,742 | 211 | 520 | 0 |
31 Mar 21 | 3,634 | 182 | 527 | 0 |
31 Dec 20 | 3,717 | 198 | 537 | 0 |
30 Sep 20 | 3,758 | 201 | 540 | 0 |
30 Jun 20 | 3,847 | 170 | 535 | 0 |
31 Mar 20 | 4,070 | 247 | 536 | 0 |
31 Dec 19 | 3,965 | 158 | 535 | 0 |
30 Sep 19 | 3,924 | 181 | 530 | 0 |
30 Jun 19 | 3,906 | 247 | 524 | 0 |
31 Mar 19 | 3,871 | 271 | 516 | 0 |
31 Dec 18 | 3,969 | 375 | 512 | 0 |
30 Sep 18 | 3,961 | 414 | 488 | 0 |
30 Jun 18 | 4,020 | 489 | 498 | 0 |
31 Mar 18 | 3,929 | 481 | 487 | 0 |
31 Dec 17 | 3,775 | 440 | 487 | 0 |
30 Sep 17 | 3,719 | 422 | 503 | 0 |
30 Jun 17 | 3,603 | 404 | 479 | 0 |
31 Mar 17 | 3,534 | 366 | 481 | 0 |
31 Dec 16 | 3,505 | 388 | 471 | 0 |
30 Sep 16 | 3,437 | 386 | 464 | 0 |
30 Jun 16 | 3,389 | 402 | 453 | 0 |
31 Mar 16 | 3,295 | 433 | 423 | 0 |
31 Dec 15 | 3,314 | 501 | 399 | 0 |
30 Sep 15 | 3,222 | 509 | 368 | 0 |
30 Jun 15 | 3,081 | 445 | 368 | 0 |
31 Mar 15 | 3,025 | 437 | 358 | 0 |
31 Dec 14 | 2,922 | 387 | 352 | 0 |
30 Sep 14 | 2,849 | 379 | 356 | 0 |
30 Jun 14 | 2,908 | 449 | 336 | 0 |
31 Mar 14 | 2,829 | 429 | 313 | 0 |
31 Dec 13 | 2,676 | 367 | 307 | 0 |
Qualität der Erträge: CMR-R has high quality earnings.
Wachsende Gewinnspanne: CMR-R's current net profit margins (5.2%) are higher than last year (3.8%).
Analyse von freiem Cashflow und Gewinn
Analyse des Gewinnwachstums in der Vergangenheit
Ergebnisentwicklung: CMR-R's earnings have grown by 9.8% per year over the past 5 years.
Beschleunigtes Wachstum: CMR-R's earnings growth over the past year (49.2%) exceeds its 5-year average (9.8% per year).
Erträge im Vergleich zur Industrie: CMR-R earnings growth over the past year (49.2%) exceeded the Healthcare industry 16.7%.
Eigenkapitalrendite
Hohe Eigenkapitalrendite: CMR-R's Return on Equity (6.8%) is considered low.